Danaher Corporation $DHR Stock Sold by Keybank National Association OH

Keybank National Association OH lessened its stake in shares of Danaher Corporation (NYSE:DHR) by 4.9% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 301,825 shares of the conglomerate’s stock after selling 15,644 shares during the period. Keybank National Association OH’s holdings in Danaher were worth $66,869,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Prime Capital Investment Advisors LLC raised its stake in shares of Danaher by 0.5% in the 3rd quarter. Prime Capital Investment Advisors LLC now owns 9,203 shares of the conglomerate’s stock valued at $2,039,000 after acquiring an additional 45 shares in the last quarter. Essential Investment Partners LLC boosted its position in Danaher by 34.6% during the third quarter. Essential Investment Partners LLC now owns 175 shares of the conglomerate’s stock worth $39,000 after purchasing an additional 45 shares during the period. Montis Financial LLC boosted its position in Danaher by 2.3% during the third quarter. Montis Financial LLC now owns 2,020 shares of the conglomerate’s stock worth $448,000 after purchasing an additional 46 shares during the period. Covestor Ltd boosted its position in Danaher by 28.3% during the third quarter. Covestor Ltd now owns 213 shares of the conglomerate’s stock worth $47,000 after purchasing an additional 47 shares during the period. Finally, Veery Capital LLC grew its holdings in Danaher by 3.1% during the third quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after purchasing an additional 48 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In related news, CAO Christopher Bouda sold 7,598 shares of the business’s stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the transaction, the chief accounting officer owned 9,107 shares of the company’s stock, valued at approximately $2,136,137.92. The trade was a 45.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Gregory M. Milosevich sold 2,100 shares of the business’s stock in a transaction on Monday, November 9th. The stock was sold at an average price of $230.62, for a total transaction of $484,302.00. Following the transaction, the executive vice president directly owned 22,367 shares in the company, valued at $5,158,277.54. This trade represents a 8.58% decrease in their position. The disclosure for this sale is available in the SEC filing. 10.80% of the stock is currently owned by corporate insiders.

Danaher Price Performance

NYSE DHR opened at $236.41 on Wednesday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The stock has a market capitalization of $166.32 billion, a PE ratio of 38.69, a P/E/G ratio of 2.95 and a beta of 0.76. The stock has a 50-day simple moving average of $221.10 and a 200 day simple moving average of $201.55.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.19. The firm had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.89 EPS. Research analysts anticipate that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were issued a dividend of $0.40 per share. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s payout ratio is 26.19%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. The Goldman Sachs Group restated a “buy” rating and issued a $275.00 price objective on shares of Danaher in a research note on Thursday, October 22nd. Stifel Nicolaus upped their price objective on shares of Danaher from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, October 22nd. Morgan Stanley raised their target price on shares of Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a research note on Monday, October 12th. Finally, Wells Fargo & Company dropped their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $242.91.

Danaher Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.